X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13412) 13412
Magazine Article (30) 30
Book Chapter (5) 5
Publication (4) 4
Government Document (3) 3
Book / eBook (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (9445) 9445
life sciences & biomedicine (9143) 9143
male (8428) 8428
humans (7587) 7587
animals (6968) 6968
piperidines - pharmacology (6305) 6305
female (5115) 5115
piperidines - administration & dosage (4710) 4710
rats (3574) 3574
piperidines - therapeutic use (3431) 3431
pharmacology & pharmacy (3195) 3195
adult (2973) 2973
middle aged (2828) 2828
dose-response relationship, drug (2431) 2431
neurosciences & neurology (2284) 2284
neurosciences (2105) 2105
aged (2035) 2035
mice (2028) 2028
piperidines - adverse effects (1832) 1832
rats, sprague-dawley (1478) 1478
pyrazoles - pharmacology (1307) 1307
time factors (1237) 1237
anesthesiology (1201) 1201
double-blind method (1177) 1177
piperidines - pharmacokinetics (1173) 1173
abridged index medicus (1161) 1161
administration, oral (1150) 1150
treatment outcome (1145) 1145
rats, wistar (1064) 1064
remifentanil (953) 953
psychiatry (948) 948
disease models, animal (876) 876
analysis (794) 794
adolescent (774) 774
receptor, cannabinoid, cb1 - antagonists & inhibitors (718) 718
oncology (667) 667
clinical neurology (661) 661
anesthetics, intravenous - administration & dosage (659) 659
research (658) 658
blood pressure - drug effects (650) 650
piperidines (598) 598
medicine & public health (590) 590
drug interactions (588) 588
piperidines - chemistry (587) 587
drug administration schedule (579) 579
mice, inbred c57bl (579) 579
donepezil (576) 576
drug therapy (570) 570
drug therapy, combination (568) 568
prospective studies (559) 559
behavior, animal - drug effects (557) 557
propofol - administration & dosage (552) 552
heart rate - drug effects (547) 547
young adult (544) 544
aged, 80 and over (537) 537
analgesics, opioid - administration & dosage (536) 536
indans - therapeutic use (524) 524
alzheimer disease - drug therapy (506) 506
pharmacology/toxicology (504) 504
biochemistry & molecular biology (501) 501
brain - metabolism (490) 490
rodents (489) 489
piperidines - metabolism (486) 486
care and treatment (478) 478
analysis of variance (471) 471
in vitro techniques (471) 471
alzheimer's disease (465) 465
clinical trials as topic (465) 465
brain - drug effects (460) 460
piperidines - blood (454) 454
motor activity - drug effects (448) 448
general & internal medicine (428) 428
anesthesia (424) 424
chemistry (422) 422
neurology (422) 422
rimonabant (415) 415
research article (413) 413
dogs (408) 408
dosage and administration (405) 405
health aspects (403) 403
infusions, intravenous (399) 399
endocrinology & metabolism (397) 397
injections, intravenous (394) 394
biomedicine (390) 390
surgery (390) 390
receptor, cannabinoid, cb1 - metabolism (388) 388
cholinesterase inhibitors - therapeutic use (383) 383
physical sciences (382) 382
physiological aspects (379) 379
indans - administration & dosage (375) 375
endocannabinoids (371) 371
pharmacology (366) 366
propofol (365) 365
child (353) 353
clinical trials (350) 350
pharmacokinetics (342) 342
indans - pharmacology (340) 340
pyridines - pharmacology (340) 340
drug synergism (325) 325
serotonin antagonists - pharmacology (321) 321
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12808) 12808
Japanese (300) 300
German (184) 184
French (106) 106
Spanish (95) 95
Italian (66) 66
Russian (62) 62
Chinese (61) 61
Polish (27) 27
Portuguese (23) 23
Hungarian (8) 8
Czech (7) 7
Norwegian (7) 7
Romanian (6) 6
Turkish (6) 6
Bulgarian (4) 4
Danish (4) 4
Dutch (4) 4
Finnish (3) 3
Serbian (2) 2
Swedish (2) 2
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Anaesthesia and intensive care, ISSN 0310-057X, 06/2005, Volume 33, Issue 3, pp. 311 - 322
The clinical utility of most analgesic drugs is altered in the presence of patients with impaired renal or hepatic function not simply because of altered... 
Analgesia: renal failure, renal function, hepatic failure, hepatic function, review | Acute pain | Anesthesiology | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Kidney Failure, Chronic - physiopathology | Analgesics - therapeutic use | Pain - drug therapy | Humans | Half-Life | Biological Availability | Metabolic Clearance Rate | Analgesics - pharmacokinetics | Liver Diseases - physiopathology | Liver Diseases - metabolism | Contraindications | Kidney Failure, Chronic - metabolism | Methadone, pharmacokinetics | Anti-Inflammatory Agents, Non-Steroidal, adverse effects | Piperidines, pharmacokinetics | Hydrocodone, pharmacokinetics | Fentanyl, pharmacokinetics | Pain, complications | Buprenorphine, pharmacokinetics | Hydrocodone, administration and dosage | Carbamazepine, pharmacokinetics | Acute Disease | Ketamine, pharmacokinetics | Sufentanil, pharmacokinetics | Propoxyphene, pharmacokinetics | Acetaminophen, adverse effects | Clonidine, administration and dosage | Morphine, administration and dosage | Oxycodone, administration and dosage | Propoxyphene, administration and dosage | Hydromorphone, administration and dosage | Methadone, administration and dosage | Alfentanil, pharmacokinetics | Buprenorphine, administration and dosage | Codeine, pharmacokinetics | Meperidine, pharmacokinetics | Sufentanil, administration and dosage | Anesthetics, Local, therapeutic use | Codeine, administration and dosage | Mexiletine, pharmacokinetics | Mexiletine, administration and dosage | Anti-Inflammatory Agents, Non-Steroidal, therapeutic use | Liver Failure, complications | Alfentanil, administration and dosage | Piperidines, administration and dosage | Pain, drug therapy | Ketamine, administration and dosage | Fentanyl, administration and dosage | Carbamazepine, administration and dosage | Hydromorphone, pharmacokinetics | Ketorolac, pharmacokinetics | Analgesics, Opioid, therapeutic use | Ketorolac, administration and dosage | Tramadol, administration and dosage | Morphine, pharmacokinetics | Valproic Acid, pharmacokinetics | Acetaminophen, administration and dosage | Valproic Acid, administration and dosage | Tramadol, pharmacokinetics | Acetic Acids | Kidney Failure, complications | Antidepressive Agents, Tricyclic, therapeutic use | Meperidine, administration and dosage | Clonidine, pharmacokinetics | Analgesics, Non-Narcotic, therapeutic use | Oxycodone, pharmacokinetics | Valproic Acid, adverse effects | Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 06/2014, Volume 370, Issue 25, pp. 2377 - 2386
Journal Article
by Fleischmann, Roy and Mysler, Eduardo and Hall, Stephen and Kivitz, Alan J and Moots, Robert J and Luo, Zhen and DeMasi, Ryan and Soma, Koshika and Zhang, Richard and Takiya, Liza and Tatulych, Svitlana and Mojcik, Christopher and Krishnaswami, Sriram and Menon, Sujatha and Smolen, Josef S and Adams, Luthando and Ally, Mahmood M and du Plooy, Maria C and Louw, Ingrid C and Nayiager, Savithree and Nel, Christoffel B and Nel, Debra and Reuter, Helmuth and Soloman, Ahmed S and Spargo, Catherine E and Rischmueller, Maureen and Sharma, Shunil D and Will, Robert K and Youssef, Peter P and Arroyo, Caroline and Baes, Rosario P and Dulos, Roger B and Hao, Llewellyn T and Lanzon, Allan E and Lichauco, Juan Javier T and Mangubat, Jill H and Ramiterre, Edgar B and Reyes, Bernadette Heizel M and Tan, Perry P and Choe, Jung-Yoon and Kang, Young Mo and Kwon, Seong Ryul and Lee, Sang-Heon and Lee, Shin-Seok and Yoo, Dae-Hyun and Lin, Hsiao-Yi and Luo, Shue-Fen and Tsai, Shih-Tzu and Tsai, Wen-Chan and Tseng, Jui-Cheng and Wei, Cheng-Chung C and Asavatanabodee, Paijit and Nantiruj, Kanokrat and Nilganuwong, Surasak and Uea-Areewongsa, Parichat and Majstorovic, Ljubinka Bozic and Bacic, Suada Mulic and Batalov, Anastas Z and Georgieva-Slavcheva, Gabriela and Mihailova, Mariyana and Nikolov, Nikolay G and Penev, Dimitar P and Spasov, Yuliy A and Stanimirova, Krasimira and Todorov, Stoyan and Toncheva, Antoaneta R and Yordanova, Nadezhda and Mosterova, Zdenka and Novosad, Libor and Prochazkova, Leona and Stehlikova, Helena and Stejfova, Zuzana and Kiseleva, Natalia and Pank, Lea and Savi, Triin and Alexandra, Balbir-Gurman and Amital, Howard and Mevorach, Dror and Rosner, Itzhak A and Mihailova, Anna and Stumbra-Stumberga, Evija and Basijokiene, Vida and Lietuvininkiene, Virginija and Unikiene, Dalia and Brzezicki, Jan and Dudek, Anna M and Glowacka-Kulesz, Maria B and Grabowicz-Wasko, Barbara and Hajduk-Kubacka, Sabina and Hilt, Joanna and Hrycaj, Pawel and Jeka, Slawomir and Kolasa, Renata and Krogulec, Marek and Mastalerz, Hanna and Olak-Popko, Anna and Owczarek, Elzbieta and Ruzga, Zofia and Walczak, Alina and Ancuta, Codrina I and ... and ORAL Strategy investigators and ORAL Strategy Investigators
The Lancet (British edition), ISSN 0140-6736, 07/2017, Volume 390, Issue 10093, pp. 457 - 468
Summary Background Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. The Oral Rheumatoid Arthritis triaL (ORAL) Strategy... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antirheumatic Agents - administration & dosage | Humans | Middle Aged | Male | Methotrexate - therapeutic use | Adalimumab - adverse effects | Arthritis, Rheumatoid - drug therapy | Pyrroles - administration & dosage | Antirheumatic Agents - adverse effects | Pyrroles - adverse effects | Adult | Female | Drug Therapy, Combination | Pyrroles - therapeutic use | Antirheumatic Agents - therapeutic use | Severity of Illness Index | Piperidines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Pyrimidines - administration & dosage | Treatment Outcome | Methotrexate - adverse effects | Adalimumab - therapeutic use | Adalimumab - administration & dosage | Piperidines - therapeutic use | Pyrimidines - therapeutic use | Piperidines - adverse effects | Pyrimidines - adverse effects | Methotrexate - administration & dosage | Rheumatoid factor | Care and treatment | Analysis | Clinical trials | Arthritis | Pharmaceutical industry | Methotrexate | Rheumatology | Patients | Evidence-based medicine | Studies | Rheumatoid arthritis | Monoclonal antibodies | Rheumatism | TNF inhibitors | Janus kinase | Tumor necrosis factor-TNF | Safety | Drug therapy | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Brain, Behavior, and Immunity, ISSN 0889-1591, 2015, Volume 51, pp. 204 - 211
Highlights • Endocannabinoids participate in the fever induced by TNF, IL-1β, IL-6, CRF and ET-1. • Endocannabinoids are not involved in the fever induced by... 
Psychiatry | Allergy and Immunology | Prostaglandins | Cytokines | β-Endorphin | Fever | Endocannabinoids | Anandamide | Neurosciences | Immunology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Narcotic Antagonists - administration & dosage | Rats, Wistar | Body Temperature - drug effects | Male | Fever - chemically induced | Cytokines - physiology | Fever - physiopathology | Receptor, Cannabinoid, CB1 - physiology | Endocannabinoids - physiology | Arachidonic Acids - administration & dosage | Interleukin-6 - physiology | Corticotropin-Releasing Hormone - administration & dosage | Interleukin-6 - administration & dosage | Arachidonic Acids - physiology | Interleukin-1beta - physiology | Piperidines - administration & dosage | beta-Endorphin - cerebrospinal fluid | Endothelin-1 - administration & dosage | Rats | Cytokines - administration & dosage | Polyunsaturated Alkamides - administration & dosage | Prostaglandins - physiology | Pyrazoles - administration & dosage | Animals | Endocannabinoids - administration & dosage | Interleukin-1beta - administration & dosage | Tumor Necrosis Factor-alpha - physiology | Tumor Necrosis Factor-alpha - administration & dosage | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Naloxone - administration & dosage | Prostaglandins - administration & dosage | Index Medicus
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 0027-8424, 11/2015, Volume 112, Issue 45, pp. 14084 - 14089
Marijuana exerts profound effects on human social behavior, but the neural substrates underlying such effects are unknown. Here we report that social contact... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Endocannabinoids - metabolism | Immunohistochemistry | Piperazines - administration & dosage | Bornanes - administration & dosage | Clozapine - administration & dosage | Nucleus Accumbens - metabolism | Bornanes - pharmacology | Male | Carbamates - administration & dosage | Oxytocin - metabolism | Receptors, Cannabinoid - metabolism | Arachidonic Acids - metabolism | Benzamides - administration & dosage | Clozapine - pharmacology | Piperidines - pharmacology | Social Behavior | Benzamides - pharmacology | Carbamates - pharmacology | Pyrazoles - pharmacology | Piperidines - administration & dosage | Benzodiazepines - pharmacology | Mice, Inbred C57BL | Clozapine - analogs & derivatives | Polyunsaturated Alkamides - metabolism | Piperazines - pharmacology | Cocaine - administration & dosage | Cocaine - pharmacology | Pyrazoles - administration & dosage | Animals | Analysis of Variance | Benzodiazepines - administration & dosage | Signal Transduction - physiology | Mice | Lipids - analysis | Reward | Infusions, Intraventricular | Autism Spectrum Disorder - physiopathology | Influence | Cellular signal transduction | Research | Oxytocin | Analysis | Endocannabinoids | Index Medicus | reward | Biological Sciences | endocannabinoid | oxytocin | anandamide | social behavior
Journal Article
Journal Article